Sphere Fluidics
https://www.spherefluidics.com
Sphere Fluidics is a life sciences company, based in Cambridgeshire, UK and New Jersey, USA. Sphere Fluidics offers a novel platform (Cyto-Mine®) that performs single cell analysis.
Cyto-Mine® reduces costs for biopharmaceutical discovery and development. It is being adapted to single cell engineering using synthetic biology or genome editing.
In the media
21st February 2020
Sphere Fluidics' Discovery Day
Taking place on March 3, 2020, the Discovery Day is a chance to gain insight from and engage with industry leaders and super users of our picodroplet technology. Join us to hear how picodroplet technology has helped to advance processes in cell line development and antibody discovery and gain novel insights from experts in the field of bioprocessing.
21st February 2020
Sphere Fluidics' Discovery Day
Taking place on March 3, 2020, the Discovery Day is a chance to gain insight from and engage with industry leaders and super users of our picodroplet technology. Join us to hear how picodroplet technology has helped to advance processes in cell line development and antibody discovery and gain novel insights from experts in the field of bioprocessing.
21st February 2020
Sphere Fluidics' Discovery Day
Taking place on March 3, 2020, the Discovery Day is a chance to gain insight from and engage with industry leaders and super users of our picodroplet technology. Join us to hear how picodroplet technology has helped to advance processes in cell line development and antibody discovery and gain novel insights from experts in the field of bioprocessing.